IL66726A0 - Improvements in or relating to thieno and furopyridinium-substituted cephalosporin derivatives - Google Patents

Improvements in or relating to thieno and furopyridinium-substituted cephalosporin derivatives

Info

Publication number
IL66726A0
IL66726A0 IL66726A IL6672682A IL66726A0 IL 66726 A0 IL66726 A0 IL 66726A0 IL 66726 A IL66726 A IL 66726A IL 6672682 A IL6672682 A IL 6672682A IL 66726 A0 IL66726 A0 IL 66726A0
Authority
IL
Israel
Prior art keywords
furopyridinium
thieno
relating
cephalosporin derivatives
substituted cephalosporin
Prior art date
Application number
IL66726A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL66726A0 publication Critical patent/IL66726A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL66726A 1981-09-08 1982-09-06 Improvements in or relating to thieno and furopyridinium-substituted cephalosporin derivatives IL66726A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30035781A 1981-09-08 1981-09-08
US34062882A 1982-01-19 1982-01-19

Publications (1)

Publication Number Publication Date
IL66726A0 true IL66726A0 (en) 1982-12-31

Family

ID=26971737

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66726A IL66726A0 (en) 1981-09-08 1982-09-06 Improvements in or relating to thieno and furopyridinium-substituted cephalosporin derivatives

Country Status (17)

Country Link
EP (1) EP0074268A3 (de)
KR (1) KR840001585A (de)
CS (1) CS232735B2 (de)
DD (1) DD209633A5 (de)
DK (1) DK399282A (de)
ES (2) ES8404361A1 (de)
FI (1) FI823088L (de)
GB (1) GB2105719A (de)
GR (1) GR76701B (de)
HU (1) HU187575B (de)
IL (1) IL66726A0 (de)
NZ (1) NZ201833A (de)
PH (1) PH19756A (de)
PL (1) PL238158A1 (de)
PT (1) PT75518B (de)
RO (1) RO84456B (de)
SU (1) SU1169542A3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5910593A (ja) * 1982-06-28 1984-01-20 Bristol Mayers Kenkyusho Kk セフアロスポリン誘導体
US4480098A (en) * 1982-11-12 1984-10-30 Eli Lilly And Company Preparation of alkali metal thieno(furo)pyridines
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
EP0137442A3 (de) * 1983-10-08 1986-01-15 Hoechst Aktiengesellschaft Cephalosporinderivate und Verfahren zu ihrer Herstellung
EP0138552A3 (de) * 1983-10-17 1986-03-19 Eli Lilly And Company Herstellung von 3-biclyclipyridinium-methyl Cephalosporinen
US4868173A (en) * 1984-11-20 1989-09-19 Ici Pharma Cephalosporin derivatives
EP0187456A1 (de) * 1984-11-29 1986-07-16 Ici Pharma Cephalosporinverbindungen
ATE89826T1 (de) * 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
GB8626245D0 (en) * 1985-11-27 1986-12-03 Ici Pharma Cephalosporin compounds
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates
US4918067A (en) * 1986-07-24 1990-04-17 Beecham Group P.L.C. Heterocyclic substituted penicillin antibiotics
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
CA2395648A1 (en) * 2000-02-10 2001-08-16 Pharmacia & Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
US6642238B2 (en) 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
US7847093B2 (en) 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
EP1618114B1 (de) 2003-04-16 2010-07-14 Sandoz AG Verfahren zur herstellung von cefepim

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
FR2440738A1 (fr) * 1978-11-13 1980-06-06 Parcor Medicament a base de derives des thieno (2,3-c) et (3,2-c) pyridines
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"

Also Published As

Publication number Publication date
PT75518B (en) 1985-11-12
FI823088L (fi) 1983-03-09
DK399282A (da) 1983-03-09
EP0074268A2 (de) 1983-03-16
GR76701B (de) 1984-08-29
ES527763A0 (es) 1985-05-16
PT75518A (en) 1982-10-01
GB2105719A (en) 1983-03-30
RO84456A (ro) 1984-06-21
ES515548A0 (es) 1984-04-16
PH19756A (en) 1986-06-26
RO84456B (ro) 1984-08-30
HU187575B (en) 1986-01-28
EP0074268A3 (de) 1984-05-23
SU1169542A3 (ru) 1985-07-23
ES8505374A1 (es) 1985-05-16
NZ201833A (en) 1985-09-13
PL238158A1 (en) 1984-11-19
CS650582A2 (en) 1984-06-18
ES8404361A1 (es) 1984-04-16
KR840001585A (ko) 1984-05-07
CS232735B2 (en) 1985-02-14
DD209633A5 (de) 1984-05-16
FI823088A0 (fi) 1982-09-07

Similar Documents

Publication Publication Date Title
JPS57192394A (en) Cephalosporin derivatives and manufacture
EG15899A (en) Improvement in or relating to n-arybenzamide derivatives
DE3163900D1 (en) Improvements in or relating to 3-aryl-5-isothiazole derivatives
IL66726A0 (en) Improvements in or relating to thieno and furopyridinium-substituted cephalosporin derivatives
EP0080442A3 (en) Di-galactose derivatives and their preparation
PT78985B (en) Improvements in or relating to cephalosporins
GB2095497B (en) Improvements in and relating to direction finding
GR81043B (en) Improvements in or relating to cephalosporin derivatives
ZA826538B (en) Thieno and furopyridinium-substituted cephalosporin derivatives
AU8300083A (en) Improvements in or relating to trailers
GB2137997B (en) Improvements in or relating to indolylglycyl cephalosporin derivatives
GB2100303B (en) Improvements in or relating to cardclothing
ZW4384A1 (en) Improvements in or relating to benzothienylglycyl cephalosporin derivatives
IL71496A0 (en) Improvements in or relating to benzothienylglycyl cephalosporin derivatives
DE3266355D1 (en) Octahydrotetracyanoquinodimethane and derivatives thereof
GB2112182B (en) Improvements in and relating to differential signal decoders
PT74879B (en) Improvements in or relating to construction
ZM1684A1 (en) Improvements in or relating to naphthylglycyl cephalosporin derivatives
AR242033A1 (es) Un procedimiento para la preparacion de un derivado de 2-amino-pirimido(4,5-g)-quinolina y lactamas de aplicacion exclusiva en dicho procedimiento.
GB2093505B (en) Improvements in or relating to tunnels
JPS57179198A (en) 3-oxo-17 alpha-ethynyl-17 beta-trifluoroacetoxy- gonane derivatives and manufacture
ZW4484A1 (en) Improvements in or relating to napthylglycyl cephalosporin derivatives
IL68500A0 (en) Improvement in or relating to naphthalenamine derivatives
IL70854A0 (en) Improvements in or relating to benzazepine derivatives
ZA812170B (en) Frlourophenacyl-amine derivatives and application thereof in therapeutics